FibroGen (FGEN) Financials

$7.50

$-1.72 (-18.66%)

As on 05-Feb-2026 09:30EDT

Market cap

$39 Mln

Revenue (TTM)

$-118 Mln

P/E Ratio

--

P/B Ratio

53.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	-118.09	29.62	46.80	140.73	235.31	176.32
Cost of Revenue	-20.39	15.56	3.96	20.28	12.87	8.87
Gross Profit	-97.71	14.06	42.84	120.45	222.44	167.45
Operating Expenses	26.33	164.48	365.56	421.48	510.97	359.33
Operating Profit (EBIT)	-124.04	-150.42	-322.72	-301.03	-288.53	-191.88
Other Income	--	--	--	--	1.01	--
Profit before Tax	-131.27	-153.37	-323.22	-293.30	-290.68	-188.93
Provision for Tax	-213.92	-0.27	-0.25	0.36	0.35	0.36
Profit after Tax (Net Income)	215.65	-47.58	-284.23	-293.65	-291.03	-189.29
Minority Interest	--	--	--	--	--	19.27
Consolidated Profit	--	--	--	-293.65	-290.02	-189.29

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	-17.03	-225.60	-204.17	-21.45	209.15	422.18
Minority Interest	--	--	--	--	19.97	19.27
Non-Current Liabilities	83.56	264.85	368.06	338.01	319.21	222.20
Current Liabilities	35.97	133.31	217.67	273.56	225.50	163.19
Total Liabilities	172.99	214.53	423.53	610.09	773.82	826.84

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	3.59	18.02	91.97	117.26	299.76	71.73
Current Assets	133.42	196.51	331.56	492.83	474.06	755.11
Total Assets	172.99	214.53	423.53	610.09	773.82	826.84
Total Debt*	19.47	90.17	170.46	89.89	99.72	39.76
Net Current Assets	97.45	63.20	113.89	219.26	248.56	591.92

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-138.00	-315.02	-145.93	-82.23	81.60
Cash Flow from Investing Activities	--	125.99	153.66	89.12	-426.97	452.49
Cash from Financing Activities	--	-0.26	122.75	46.78	-0.56	13.34
Net Cash Inflow / Outflow	--	--	--	--	-509.77	547.43

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	52.24	-11.80	-2.89	-3.12	-3.14	-2.08
Cash EPS ($)	--	-11.13	-2.78	-3.01	-2.98	-1.83
Adjusted Book Value ($)	--	--	--	--	2.25	4.63
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-34.22	-3.20	-1.55	-0.89	0.90
Free Cash Flow per Share ($)	--	-34.28	-3.22	-1.96	-1.21	0.85

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	56.26	-1,636.95	-155.66	-75.51	-36.19
ROE (%)	--	22.14	251.96	-312.90	-92.20	-40.35
ROA (%)	68.69	-14.91	-55.00	-42.44	-36.36	-22.48
EBIT Margin (%)	109.06	-489.92	-673.31	-208.50	-122.62	-105.68
Net Margin (%)	-182.61	-160.63	-607.29	-208.66	-123.15	-107.36
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	-218.29	-0.37	-0.67	-0.40	0.33	-0.31
EBIT Growth (%)	19.64	53.95	-7.39	-1.70	-54.85	-152.59
Net Profit Growth (%)	277.07	83.26	3.21	-0.90	-53.75	-145.93
EPS Growth (%)	677.48	-3.09	0.08	0.00	-0.51	-1.36
Book Value Growth (%)	93.05	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-0.04	-0.31	-5.13	-4.49	-17.86
Price / Book Value	53.83	-0.01	-0.43	-70.24	6.25	8.01
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.17	-0.29	-0.07	-4.15	-3.66	-16.65
Close Price ($)	12.25	13.24	22.15	400.50	352.50	927.25
High Price ($)	21.94	73.25	642.25	457.75	1,430.22	1,289.00
Low Price ($)	4.50	4.50	8.33	195.25	247.00	566.25
Market Cap ($ Cr)	39.28	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	-0.40	-0.83	-4.19	0.48	0.09
Short term debt to equity ratio	--	--	-0.07	-0.48	0.05	0.03
Current Ratio	3.71	1.47	1.52	1.80	2.10	4.63
Quick Ratio	3.60	1.45	1.33	1.65	1.96	4.53
Interest Coverage	-14.33	-17.60	-38.93	-203.77	-134.01	-77.57

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	-0.10	1.62	87.71	11.58	10.79	23.75
Asset Turnover	-0.38	0.09	0.09	0.20	0.29	0.21
Receivable days	--	256.07	223.79	54.11	52.22	72.85
Inventory Days	--	524.84	3,779.77	643.43	674.61	482.19
Payable days	--	270.21	2,245.61	511.99	722.02	635.80
Cash Conversion Cycle	--	510.70	1,757.94	185.55	4.81	-80.76

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.